News

French start-up Sorella secures €5m in funding to enhance tech for women’s health

French health tech start-up Sorella has successfully secured €5 million in funding, which is set to go towards advancing the company’s tech for women’s health and the expansion of its multidisciplinary health clinics for women.

In a LinkedIn post, Sorella announced the results of its latest fundraising efforts, calling the funding “the beginning of a new phase for Sorella”, and committing to improving coordinated care and personalised support for women; developing the company’s digital platform to improve patient care pathways; and further expanding its solutions across France to treat more women.

The post highlights the successful funding as validating “our unique model of multidisciplinary care, so we can continue to revolutionise women’s health”, and extends thanks to lead investors blisce and Vorwerk Ventures.

Specialising in areas including gynaecology, obstetrics, cardiology and ultrasound, Sorella’s website highlights its digital platform for “complete follow-up and personalised care”, incorporating a digitalised medical record and personalised content written by health professionals for stages from puberty all the way through to post-menopause.

For health professionals, Sorella’s platform helps promote visibility of patient medical history and medical needs, promoting smoother patient management processes, and enabling healthcare providers to enhance their efficiency in providing care.

Also in funding, Earlybird Health, a Germany-based venture capital firm with a focus on the health tech market in Europe, has announced the closure of its second fund at €173 million. The fund will be primarily dedicated to investing in European health tech companies ranging from early development to those “nearing regulatory approval and commercialisation”.

Elsewhere, Dutch company NLC Health Ventures has announced that it has secured a total of €58 million in funding, including €14 million from a recent funding round, which will be used to “accelerate NLC’s strategic plans for international expansion”, increasing the number of ventures built and “strengthening support” for its existing portfolio.